ONTEX Ontex Group N.V.

Ontex announces intention to restructure its production and distribution activities in Belgium, with strategic investment in refocused activity

Ontex announces intention to restructure its production and distribution activities in Belgium, with strategic investment in refocused activity

Aalst, Belgium, 13 June 2024 – Today, Ontex Group NV (Euronext: Ontex), a leading international developer and producer of personal care products, announces the intention to restructure its Belgian production and distribution activities, as part of its strategic transformation to strengthen its competitive position in the European market. This intended restructuring would entail the closure of the Eeklo site, as well as the transformation of the Buggenhout site into a Center of Excellence for research, development and production of medium & heavy incontinence care products, enabled by investments in the range of €40 million. The intended restructuring would lead to the reduction of 489 employees in Eeklo and Buggenhout, bringing the total workforce in Belgium to 569 positions, spread over the Buggenhout and Aalst sites.

Gustavo Calvo Paz, Chief Executive Officer at Ontex, confirms: “The intended transformation of our Belgian operations is part of our transformation journey, with a clear ambition to strengthen our competitive position. Ultimately, it is our mission to continue to bring affordable care products to people of all generations. It is our firm belief that the site in Buggenhout can contribute to delivering on that promise by focusing on selected adult care categories. We are convinced that our substantial investment plan of around €40 million can enable our teams to build a strong future for the site in Buggenhout.” 

In response to the increasingly competitive personal care market, Ontex is implementing its global transformation plan to strengthen its competitiveness, with a strong focus on customer-centricity, sustainable innovation and organizational and operational cost-efficiency. Since the launch of the transformation plan, numerous initiatives have been implemented, enabling the Group to improve its financial results. These early results provide confidence to pursue the structural transformation to regain and strengthen competitiveness.  

The intended optimization of Ontex’s Belgian production and distribution activities is an essential strategic initiative aimed at strengthening Ontex’s operational cost-efficiency across Europe. Consequently, Ontex today announced its intention to transform its Belgian operations footprint by exiting the Eeklo site and transforming the Buggenhout site into a center of excellence for medium and heavy incontinence products.

Ontex intends to invest an amount in the range of €40 million spread over the coming years into its Buggenhout centre of excellence, aiming to harmonize and modernize the infrastructure and production lines for medium & high incontinence, with high focus on automation. The R&D center and commercial activities, including sales and customer services, would remain in place.

The feminine and baby care products volumes produced in Eeklo and the light incontinence products produced in Buggenhout are intended to be relocated to other Ontex plants in Europe, aiming for an optimal cost model to serve the retail and healthcare markets.

The intended closure of the Eeklo site would have an impact on all current 349 production-related employees, and the intended reorganization of the Buggenhout site would impact 140 out of 528 employees. Today, the works councils in Eeklo and Buggenhout were informed in line with the legal information and consultation procedure. If – following consultation with the works councils - the intention would be confirmed, the legal procedure would be followed and Ontex would do its utmost best to offer support to all employees involved. In Belgium, Ontex would continue to employ 569 employees, based in Buggenhout and Aalst.

Jonas Deroo, Chief Human Resources Officer, confirms: “We recognize that this is a difficult announcement for our employees in Eeklo and Buggenhout and their families. Our first priority now is to ensure they are well-informed and supported. Also, throughout the process we aim for a constructive and respectful dialogue with our social partners and, if the intention of the restructuring would be confirmed, we expect to be able to find appropriate supporting measures in the interest of all affected employees.”

***

Contact information

  • Investors     Geoffroy Raskin          

  • Media            Maarten Verbanck     

About Ontex

Ontex is a leading international developer and producer of personal care products for retailers and healthcare, with expertise in baby care, feminine care and adult care. Ontex’s innovative products are distributed in around 100 countries through retailers and healthcare providers. Employing some 7,200 people all over the world, Ontex has a presence in 17 countries, with its headquarters in Aalst, Belgium. Ontex is listed on Euronext Brussels and is part of the Bel Mid®.

ONTEX GROUP NV Korte Keppestraat 21 9320 Erembodegem (Aalst) 0550.880.915 RPR Ghent – Division Dendermonde, Belgium

Attachment



EN
13/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ontex Group N.V.

 PRESS RELEASE

Ontex introduces lower-carbon bio-based absorbent material in diapers

Ontex introduces lower-carbon bio-based absorbent material in diapers Aalst, Belgium, July 9, 2025 – Ontex Group NV [EURONEXT: ONTEX], a leading international developer and producer of personal care solutions, is advancing its sustainability journey with the introduction of bio-based superabsorbent polymers (bioSAP) in its diapers, with an initial rollout in selected Moltex Pure and Nature products. This new material will gradually and incrementally replace virgin fossil-based plastic SAP in the core absorbent component, helping lower the carbon footprint of the product while maintaining pe...

 PRESS RELEASE

Ontex introduceert CO2-arm, biogebaseerd absorberend materiaal in luie...

Ontex introduceert CO2-arm, biogebaseerd absorberend materiaal in luiers Aalst, België, 9 juli 2025 – Ontex Group NV [EURONEXT: ONTEX], een toonaangevende internationale ontwikkelaar en producent van producten in babyverzorging, dameshygiëne en volwassenenzorg, zet een volgende stap in zijn duurzaamheidstraject met de introductie van biogebaseerde superabsorberende polymeren (bioSAP) in zijn luiers, met een eerste uitrol in geselecteerde Moltex Pure and Nature-producten. Dit nieuwe materiaal zal geleidelijk en stapsgewijs SAP gemaakt van ‘nieuwe’ fossiele grondstoffen in de absorberende ker...

 PRESS RELEASE

Transparency Declaration Notification

Transparency Declaration Notification Regulated information In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notification of significant shareholdings that it has received on July 3, 2025. On June 30, 2025, Brandes investment partners, L.P., detained 5,256,435 Ontex voting securities or voting rights, representing 6.38% of voting securities, and thereby crossed upward the threshold of 5%.   Notification details Reason for the notification: A...

 PRESS RELEASE

Kennisgeving transparantieverklaring

Kennisgeving transparantieverklaring Gereglementeerde informatie   In overeenstemming met de vereisten van artikel 14 van de Belgische wet van 2 mei 2007 over de openbaarmaking van belangrijke deelnemingen in emittenten, maakt Ontex Group NV (“Ontex”) de verklaring van belangrijke deelnemingen bekend die op 3 juli 2025 werd ontvangen. Op 30 juni 2024 bezat BPCE SA, Brandes investment partners, L.P.,  5.256.435 stemrechtverlenende effecten of stemrechten van Ontex, wat 6,38% van de stemverlenende effecten voorstelt. Zij hebben daarmee de drempel van 5% opwaarts overschreden.   Kenn...

Maxime Stranart
  • Maxime Stranart

Ontex/Another year of heavy restructuring ahead/HOLD (Change in primar...

We downgrade Ontex from Buy to HOLD and cut our target price from €13.83 to €8.2 following a change in primary analyst. We expect 2025 to be another year of heavy restructuring, leading to peak capex which is required, in our view, to modernise its industrial footprint and enable it to compete profitably on larger contracts going forwards. We see this limiting Ontex's organic growth in the short term to 2.7% in FY25F, despite capex on sales of c.6%. Although €115m in divestment proceeds is expec...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch